Ledger.Open graph →
SEC Form D · Amendment · filed February 27, 2019

NEUROONE MEDICAL TECHNOLOGIES Corp

Offering
$10.0M
Sold
$1.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Minnetonka, MN
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Paul A. Buckman · Minnetonka, MNDirectorMark A. Christianson · Minnetonka, MNExecDavid A. Rosa · Minnetonka, MNExec · DirectorThomas A. Bachinski · Lakeville, MNExecJeffrey S. Mathiesen · Minnetonka, MNDirectorSuraj A. Kalia · Minnetonka, MNDirectorAnusha P. Iyer · VIENNA, VADirectorWestbrook Weaver · San Diego, CADirectorJ. B. Ryan · Houston, TXExecDavid N. Ambrose · MONROVIA, CAExec · DirectorWalter Gilbert · Cambridge, MAExecThomas Powell · Reno, NVExecJan Hammer · MENLO PARK, CAExec · DirectorBaiju Bhatt · MENLO PARK, CADirectorDaniel Gallagher · MENLO PARK, CAExecJason Warnick · MENLO PARK, CADirectorSuraj A. Kalia · Minnetonka, MNDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗